The independent platform for news, articles and advice for professionals in laboratory medicine

Vésale Bioscience receives €1.8M Euro grant for PhageDiag

Vésale Bioscience is to receive €1.8M in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using artificial intelligence that enables decentralised diagnostics and personalised treatment.

Vésale Bioscience’s selected project, PhageDiag, is a fast and user-friendly diagnostic technology, or phagogram, for personalised phage therapy. It is the first automated in vitro diagnostic tool that enables a quick determination of suitable bacteriophages for treating a particular bacterial infection. PhageDiag consists of a basic test kit (a disposable well plate with reagents), a high-performance luminometer and a dedicated software that offers the best matching phage combination to treat the patient, using artificial intelligence.

The EIC Accelerator jury highlighted in its decision that: “Vésale Bioscience is tackling the AMR global issue by developing a clear diagnosis that allows a personalised phage treatment which potentially gives a higher rate of success.” According to the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the top ten global public health threats facing humanity.

“Personalised phage therapy using magistral preparations of phages is among the most promising solutions to fight antimicrobial resistant infections. This approach requires a rapid diagnostic test to identify the pathogens involved in the infection and choose the phages that would be active on them,” said Dr Johan Quintens, Chief Scientific Officer at Vésale Bioscience. “Unlike current diagnostic methods, which take up to four to seven days, the PhageDiag phagogram compares the activity of up to 96 phages on a bacterial culture within two to three hours, making phage susceptibility testing accessible for hospital microbiology labs and enabling personalised therapy on a routine basis.”

“We work in close collaboration with the Belgian regulators. This was an additional factor in the EIC Accelerator jury's decision to award us this grant for our PhageDiag project. It allows us to act as a ‘test’ case for Europe,” said Gunther Vanwezer, CEO of Vésale Bioscience.

The EIC is Europe’s flagship innovation program to identify, develop and scale-up breakthrough technologies and game changing innovations. Over a thousand start-ups and SMEs submitted a full application to obtain funding from the EIC this year. Vésale Bioscience is among 78 companies that the EIC Accelerator selected at the end of 2022 to receive a grant.

 

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025